PEPG net incomeQ3 2026-$19.39M
PEPG net income was -$19.39M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$18.03M a year earlier. For the full fiscal 2025 it was -$89.66M, compared with -$89.98M in fiscal 2024.
PepGen Inc. (PEPG) financials
For the twelve months ended Sep 30, 2026, PepGen Inc. reported -$73.31M of net income.
- Net income, TTM
- -$73.31M
- Free cash flow, TTM
- -$63.28M
- Cash
- $21.96M
- Market cap
- $319.3M
FY2021FY2025
FY2021FY2025
PEPG revenue and earnings growth
PEPG EPSQ3 2026-$0.28
PEPG diluted EPS was -$0.28 in fiscal Q3 2026 (ended Sep 30, 2026). For the full fiscal 2025 it was -$2.12, compared with -$2.85 in fiscal 2024.
PEPG free cash flowQ3 2026-$13.18M
PEPG free cash flow was -$13.18M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$19.36M a year earlier. For the full fiscal 2025 it was -$81.90M, compared with -$82.87M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|
| Research and development | $71.04M | $76.48M | $68.13M | $54.08M | $19.00M |
| Selling, general and admin | $22.57M | $21.26M | $16.64M | $14.22M | $8.11M |
| Operating income | -$93.61M | -$97.74M | -$84.77M | -$68.30M | -$27.11M |
| Pre-tax income | -$89.61M | -$90.60M | -$78.55M | -$65.40M | -$27.28M |
| Income tax | $48.9K | -$617.0K | $73.0K | $3.70M | $0 |
| Net income | -$89.66M | -$89.98M | -$78.63M | -$69.10M | -$27.28M |
| EPS, basic | -$2.12 | -$2.85 | -$3.30 | -$4.42 | -$30.27 |
| EPS, diluted | -$2.12 | -$2.85 | -$3.30 | -$4.42 | -$30.27 |
| Diluted shares | 42.2M | 31.6M | 23.8M | 15.6M | 901,108 |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|
| Cash and equivalents | $60.51M | $49.42M | $80.77M | $181.75M | $132.90M |
| Short-term investments | $87.94M | $70.77M | $29.63M | $0 | - |
| Current assets | $150.96M | $123.76M | $112.68M | $186.08M | $139.99M |
| Total assets | $173.91M | $150.88M | $143.05M | $217.44M | $143.64M |
| Current liabilities | $12.65M | $16.70M | $17.53M | $18.83M | $10.32M |
| Total liabilities | $26.46M | $32.26M | $34.63M | $37.81M | $10.55M |
| Shareholders' equity | $147.44M | $118.62M | $108.42M | $179.63M | -$32.08M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$81.64M | -$82.37M | -$69.00M | -$59.27M | -$22.60M |
| Capital expenditures | $264.0K | $497.0K | $2.60M | $3.75M | $500.0K |
| Free cash flow | -$81.90M | -$82.87M | -$71.60M | -$63.02M | -$23.10M |
| Investing cash flow | -$15.23M | -$37.67M | -$32.00M | -$3.75M | -$500.0K |
| Financing cash flow | $107.98M | $88.75M | -$189.0K | $112.19M | $147.66M |
| Stock-based compensation | $10.61M | $11.46M | $7.05M | $4.76M | $1.53M |
| Depreciation and amortization | $1.40M | $1.50M | $1.20M | $500.0K | $200.0K |
Key ratios
Income statement
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $14.48M | $12.52M | $13.00M | $13.85M | $13.42M | $18.39M | $25.38M | $18.96M | $17.72M | $25.06M | $14.73M | $16.30M |
| Selling, general and admin | $5.91M | $6.42M | $5.94M | $5.85M | $5.23M | $5.54M | $5.94M | $5.38M | $5.45M | $5.36M | $5.07M | $4.51M |
| Operating income | -$20.38M | -$18.94M | -$18.94M | -$19.70M | -$18.65M | -$23.93M | -$31.32M | -$24.34M | -$23.17M | -$30.43M | -$19.80M | -$20.81M |
| Pre-tax income | -$19.38M | -$17.80M | -$17.75M | -$18.29M | -$18.03M | -$23.09M | -$30.20M | -$22.86M | -$21.38M | -$28.34M | -$18.02M | -$19.42M |
| Income tax | $13.0K | $16.0K | $15.0K | $48.9K | $0 | $0 | $0 | -$617.0K | $0 | $0 | $0 | - |
| Net income | -$19.39M | -$17.81M | -$17.76M | -$18.34M | -$18.03M | -$23.09M | -$30.20M | -$22.24M | -$21.38M | -$28.34M | -$18.02M | -$19.50M |
| EPS, basic | -$0.28 | -$0.26 | -$0.26 | - | -$0.52 | -$0.70 | -$0.92 | -$0.69 | -$0.66 | -$0.87 | -$0.63 | -$0.81 |
| EPS, diluted | -$0.28 | -$0.26 | -$0.26 | - | -$0.52 | -$0.70 | -$0.92 | -$0.69 | -$0.66 | -$0.87 | -$0.63 | -$0.81 |
| Diluted shares | 69.3M | 69.2M | 69.1M | - | 34.4M | 32.7M | 32.7M | - | 32.6M | 32.5M | 28.7M | - |
Balance sheet
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $21.96M | $22.76M | $42.15M | $60.51M | $142.78M | $35.07M | $43.63M | $49.42M | $42.29M | $66.08M | $133.85M | $80.77M |
| Short-term investments | $82.85M | $94.47M | $90.15M | $87.94M | $20.89M | $39.58M | $54.15M | $70.77M | $96.57M | $95.22M | $41.37M | $29.63M |
| Current assets | $107.57M | $120.33M | $134.27M | $150.96M | $166.21M | $77.49M | $101.05M | $123.76M | $142.37M | $164.78M | $177.62M | $112.68M |
| Total assets | $127.78M | $141.40M | $156.29M | $173.91M | $190.06M | $102.24M | $127.39M | $150.88M | $170.23M | $193.51M | $207.00M | $143.05M |
| Current liabilities | $12.36M | $9.01M | $8.96M | $12.65M | $12.64M | $16.36M | $20.43M | $16.70M | $16.81M | $22.11M | $11.26M | $17.53M |
| Total liabilities | $24.71M | $21.86M | $22.32M | $26.46M | $26.92M | $31.08M | $35.59M | $32.26M | $32.78M | $38.47M | $28.00M | $34.63M |
| Shareholders' equity | $103.07M | $119.53M | $133.98M | $147.44M | $163.14M | $71.16M | $91.81M | $118.62M | $137.46M | $155.04M | $179.00M | $108.42M |
Cash flow
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$13.18M | -$15.81M | -$18.43M | -$15.85M | -$19.26M | -$23.60M | -$22.93M | -$19.48M | -$24.01M | -$16.35M | -$22.53M | -$19.42M |
| Capital expenditures | $0 | $30.0K | $0 | -$1.0K | $97.0K | $43.0K | $125.0K | $228.0K | $185.0K | $31.0K | $53.0K | $184.0K |
| Free cash flow | -$13.18M | -$15.84M | -$18.43M | -$15.85M | -$19.36M | -$23.64M | -$23.05M | -$19.70M | -$24.20M | -$16.38M | -$22.59M | -$19.61M |
| Investing cash flow | $12.46M | -$3.52M | -$1.46M | -$66.24M | $18.90M | $14.96M | $17.15M | $26.50M | -$133.0K | -$52.74M | -$11.29M | -$29.59M |
| Financing cash flow | -$86.0K | -$65.0K | $1.52M | -$171.0K | $108.05M | $98.0K | $0 | $128.0K | $327.0K | $1.33M | $86.97M | $26.0K |
| Stock-based compensation | $2.96M | $3.31M | $2.85M | $2.44M | $2.38M | $2.36M | $3.43M | $3.35M | $3.23M | $2.86M | $2.02M | $1.92M |
| Depreciation and amortization | $200.0K | $300.0K | $300.0K | $300.0K | $300.0K | $300.0K | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K | $400.0K |
Key ratios
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 8.70 | 13.36 | 14.98 | 11.94 | 13.15 | 4.74 | 4.95 | 7.41 | 8.47 | 7.45 | 15.78 | 6.43 |
Source: XBRL data PepGen Inc. files with the SEC, latest filing dated Nov 10, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
PEPG peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| PEPG | - | - | -$73.31M | - | $319.3M |
| LLY | $86.46B | +45.5% | $27.58B | 31.9% | $1.35T |
| JNJ | $99.33B | +7.8% | $16.09B | 16.2% | $675.92B |
| ABBV | $66.01B | +10.7% | $10.34B | 15.7% | $519.48B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $364.98B |
| NVS | $54.53B | +8.4% | $13.98B | 25.6% | $311.52B |
| AZN | $58.74B | +8.6% | $10.22B | 17.4% | $289.61B |
| ABT | $48.23B | +10.0% | $4.70B | 9.7% | $191.31B |
| NVO | DKK 309.06B | +6.4% | DKK 102.43B | 33.1% | $180.22B |
PEPG FAQ
5 questionsIs PEPG profitable?
No. PepGen Inc. reported a net loss of $73.31M for the twelve months ended Sep 30, 2026.How much cash and debt does PEPG have?
PepGen Inc. reported $21.96M in cash and cash equivalents on its most recent balance sheet in SEC filings.What is PEPG free cash flow?
PepGen Inc. generated -$63.28M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of -$63.25M less capital expenditures.When did PEPG last report financial results?
The latest statements here come from PepGen Inc.'s 10-Q filed on Nov 10, 2026, covering the period ended Sep 30, 2026.Where does this PEPG financial data come from?
Quantisnow builds these statements from the structured XBRL data PepGen Inc. files with the SEC. It is provided for information only and is not investment advice.